HEADER TRANSLATION FACTOR/ANTIBIOTIC 12-OCT-11 3U6K TITLE EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDK733 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGATION FACTOR TU 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: EF-TU 1, P-43; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: THIOCILLIN GE2270 ANALOGUE NVP-LDK733; COMPND 8 CHAIN: C, D; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 GENE: TUFA, B3339, JW3301; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES KEYWDS TRANSLATION FACTOR-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.J.PALESTRANT REVDAT 3 15-NOV-23 3U6K 1 REMARK SEQADV SEQRES HETSYN REVDAT 3 2 1 LINK ATOM REVDAT 2 18-APR-12 3U6K 1 COMPND REVDAT 1 08-FEB-12 3U6K 0 JRNL AUTH M.J.LAMARCHE,J.A.LEEDS,K.AMARAL,J.T.BREWER,S.M.BUSHELL, JRNL AUTH 2 J.M.DEWHURST,J.DZINK-FOX,E.GANGL,J.GOLDOVITZ,A.JAIN, JRNL AUTH 3 S.MULLIN,G.NECKERMANN,C.OSBORNE,D.PALESTRANT,M.A.PATANE, JRNL AUTH 4 E.M.RANN,M.SACHDEVA,J.SHAO,S.TIAMFOOK,L.WHITEHEAD,D.YU JRNL TITL ANTIBACTERIAL OPTIMIZATION OF 4-AMINOTHIAZOLYL ANALOGUES OF JRNL TITL 2 THE NATURAL PRODUCT GE2270 A: IDENTIFICATION OF THE JRNL TITL 3 CYCLOALKYLCARBOXYLIC ACIDS. JRNL REF J.MED.CHEM. V. 54 8099 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21999529 JRNL DOI 10.1021/JM200938F REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.04 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 30572 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.298 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1590 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 30572 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.60 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6108 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 145 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3U6K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000068369. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32122 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 HEPES PH 7.5, 0.3 MGCL2, 21% REMARK 280 PEG3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.18600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.95000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.10800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.95000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.18600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.10800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE GE2270A-LIKE ANTIBIOTIC COMPOUND IS REPRESENTED AS POLYMER. THE REMARK 400 FIRST 11 RESIDUES OF THE ANTIBIOTIC ARE IDENTICAL TO THE REMARK 400 CORRESPONDING RESIDUES IN GE2270A, WITH ONLY THE LAST RESIDUE REMARK 400 MODIFIED REMARK 400 REMARK 400 THE THIOCILLIN GE2270 ANALOGUE NVP-LDK733 IS THIOPEPTIDE, A MEMBER REMARK 400 OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: THIOCILLIN GE2270 ANALOGUE NVP-LDK733 REMARK 400 CHAIN: C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 LYS A 2 REMARK 465 GLU A 3 REMARK 465 LYS A 4 REMARK 465 PHE A 5 REMARK 465 GLU A 6 REMARK 465 ARG A 7 REMARK 465 MET B 0 REMARK 465 ALA B 1 REMARK 465 LYS B 2 REMARK 465 GLU B 3 REMARK 465 LYS B 4 REMARK 465 PHE B 5 REMARK 465 GLU B 6 REMARK 465 ARG B 7 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG B 230 CZ ARG B 230 NH1 -0.093 REMARK 500 ARG B 230 CA ARG B 230 C -0.188 REMARK 500 ARG B 230 C ARG B 230 O -0.261 REMARK 500 SER C 1 CA SER C 1 CB -0.099 REMARK 500 SER D 1 CA SER D 1 CB -0.096 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 38 -88.37 -79.11 REMARK 500 ARG A 58 68.83 38.63 REMARK 500 THR A 108 -76.13 -38.23 REMARK 500 ASP A 142 -128.75 71.80 REMARK 500 GLU A 143 -154.46 -91.95 REMARK 500 GLU A 144 47.55 -81.80 REMARK 500 ASP A 161 5.90 87.48 REMARK 500 PRO A 163 76.66 -66.24 REMARK 500 GLU A 215 -63.45 -92.95 REMARK 500 VAL A 231 109.64 -52.93 REMARK 500 ILE A 247 -28.91 75.39 REMARK 500 LYS A 248 -167.69 -172.69 REMARK 500 ARG A 327 70.14 62.88 REMARK 500 ARG A 333 -98.98 60.40 REMARK 500 MET A 368 144.07 -171.20 REMARK 500 ASP A 370 135.21 -38.63 REMARK 500 VAL B 14 -164.41 -128.69 REMARK 500 VAL B 34 -82.07 -55.37 REMARK 500 TYR B 39 -11.49 -143.38 REMARK 500 ALA B 57 -79.69 -69.14 REMARK 500 ARG B 58 -60.06 -128.80 REMARK 500 ALA B 96 -86.36 -82.34 REMARK 500 GLN B 97 76.32 92.69 REMARK 500 ASP B 109 -64.69 -124.84 REMARK 500 PRO B 111 85.85 -58.42 REMARK 500 MET B 112 -178.69 -67.90 REMARK 500 ASP B 142 92.31 -59.52 REMARK 500 ASP B 161 -17.49 92.49 REMARK 500 ILE B 188 -71.55 -60.47 REMARK 500 GLU B 215 -64.48 -91.37 REMARK 500 ILE B 247 -81.92 66.08 REMARK 500 PHE B 261 51.92 35.51 REMARK 500 ARG B 333 -86.78 67.42 REMARK 500 VAL C 5 -37.01 -145.91 REMARK 500 VAL D 5 -51.71 -143.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL A 140 ASP A 141 -128.92 REMARK 500 ASP A 142 GLU A 143 -110.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 394 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 25 OG1 REMARK 620 2 HOH A 439 O 72.9 REMARK 620 3 HOH A 441 O 67.2 140.1 REMARK 620 4 HOH A 442 O 97.1 113.0 72.3 REMARK 620 5 HOH A 444 O 154.3 94.8 121.9 108.5 REMARK 620 6 GDP A 500 O3B 65.8 75.3 88.8 158.7 89.6 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 394 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR B 25 OG1 REMARK 620 2 HOH B 395 O 79.2 REMARK 620 3 HOH B 396 O 60.3 134.9 REMARK 620 4 HOH B 397 O 70.7 103.0 82.8 REMARK 620 5 HOH B 403 O 149.6 110.9 97.1 130.1 REMARK 620 6 GDP B 500 O3B 68.9 71.1 76.1 139.6 86.9 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDP A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 394 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDP B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 394 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF NVP-LDK733 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF NVP-LDK733 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3U6B RELATED DB: PDB REMARK 900 EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDI028 REMARK 900 RELATED ID: 3U2Q RELATED DB: PDB REMARK 900 EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LFF571 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE GE2270A-LIKE ANTIBIOTIC COMPOUND IS REPRESENTED AS POLYMER. THE REMARK 999 FIRST 11 RESIDUES OF THE ANTIBIOTIC ARE IDENTICAL TO THE REMARK 999 CORRESPONDING RESIDUES IN GE2270A, WITH ONLY THE LAST RESIDUE REMARK 999 MODIFIED. DBREF 3U6K A 2 393 UNP P0CE47 EFTU1_ECOLI 3 394 DBREF 3U6K B 2 393 UNP P0CE47 EFTU1_ECOLI 3 394 DBREF 3U6K C 1 12 UNP Q7M0J8 THCL_PLARO 1 12 DBREF 3U6K D 1 12 UNP Q7M0J8 THCL_PLARO 1 12 SEQADV 3U6K MET A 0 UNP P0CE47 EXPRESSION TAG SEQADV 3U6K ALA A 1 UNP P0CE47 EXPRESSION TAG SEQADV 3U6K MET B 0 UNP P0CE47 EXPRESSION TAG SEQADV 3U6K ALA B 1 UNP P0CE47 EXPRESSION TAG SEQADV 3U6K 9BB C 12 UNP Q7M0J8 CYS 12 SEE REMARK 999 SEQADV 3U6K 9BB D 12 UNP Q7M0J8 CYS 12 SEE REMARK 999 SEQRES 1 A 394 MET ALA LYS GLU LYS PHE GLU ARG THR LYS PRO HIS VAL SEQRES 2 A 394 ASN VAL GLY THR ILE GLY HIS VAL ASP HIS GLY LYS THR SEQRES 3 A 394 THR LEU THR ALA ALA ILE THR THR VAL LEU ALA LYS THR SEQRES 4 A 394 TYR GLY GLY ALA ALA ARG ALA PHE ASP GLN ILE ASP ASN SEQRES 5 A 394 ALA PRO GLU GLU LYS ALA ARG GLY ILE THR ILE ASN THR SEQRES 6 A 394 SER HIS VAL GLU TYR ASP THR PRO THR ARG HIS TYR ALA SEQRES 7 A 394 HIS VAL ASP CYS PRO GLY HIS ALA ASP TYR VAL LYS ASN SEQRES 8 A 394 MET ILE THR GLY ALA ALA GLN MET ASP GLY ALA ILE LEU SEQRES 9 A 394 VAL VAL ALA ALA THR ASP GLY PRO MET PRO GLN THR ARG SEQRES 10 A 394 GLU HIS ILE LEU LEU GLY ARG GLN VAL GLY VAL PRO TYR SEQRES 11 A 394 ILE ILE VAL PHE LEU ASN LYS CYS ASP MET VAL ASP ASP SEQRES 12 A 394 GLU GLU LEU LEU GLU LEU VAL GLU MET GLU VAL ARG GLU SEQRES 13 A 394 LEU LEU SER GLN TYR ASP PHE PRO GLY ASP ASP THR PRO SEQRES 14 A 394 ILE VAL ARG GLY SER ALA LEU LYS ALA LEU GLU GLY ASP SEQRES 15 A 394 ALA GLU TRP GLU ALA LYS ILE LEU GLU LEU ALA GLY PHE SEQRES 16 A 394 LEU ASP SER TYR ILE PRO GLU PRO GLU ARG ALA ILE ASP SEQRES 17 A 394 LYS PRO PHE LEU LEU PRO ILE GLU ASP VAL PHE SER ILE SEQRES 18 A 394 SER GLY ARG GLY THR VAL VAL THR GLY ARG VAL GLU ARG SEQRES 19 A 394 GLY ILE ILE LYS VAL GLY GLU GLU VAL GLU ILE VAL GLY SEQRES 20 A 394 ILE LYS GLU THR GLN LYS SER THR CYS THR GLY VAL GLU SEQRES 21 A 394 MET PHE ARG LYS LEU LEU ASP GLU GLY ARG ALA GLY GLU SEQRES 22 A 394 ASN VAL GLY VAL LEU LEU ARG GLY ILE LYS ARG GLU GLU SEQRES 23 A 394 ILE GLU ARG GLY GLN VAL LEU ALA LYS PRO GLY THR ILE SEQRES 24 A 394 LYS PRO HIS THR LYS PHE GLU SER GLU VAL TYR ILE LEU SEQRES 25 A 394 SER LYS ASP GLU GLY GLY ARG HIS THR PRO PHE PHE LYS SEQRES 26 A 394 GLY TYR ARG PRO GLN PHE TYR PHE ARG THR THR ASP VAL SEQRES 27 A 394 THR GLY THR ILE GLU LEU PRO GLU GLY VAL GLU MET VAL SEQRES 28 A 394 MET PRO GLY ASP ASN ILE LYS MET VAL VAL THR LEU ILE SEQRES 29 A 394 HIS PRO ILE ALA MET ASP ASP GLY LEU ARG PHE ALA ILE SEQRES 30 A 394 ARG GLU GLY GLY ARG THR VAL GLY ALA GLY VAL VAL ALA SEQRES 31 A 394 LYS VAL LEU GLY SEQRES 1 B 394 MET ALA LYS GLU LYS PHE GLU ARG THR LYS PRO HIS VAL SEQRES 2 B 394 ASN VAL GLY THR ILE GLY HIS VAL ASP HIS GLY LYS THR SEQRES 3 B 394 THR LEU THR ALA ALA ILE THR THR VAL LEU ALA LYS THR SEQRES 4 B 394 TYR GLY GLY ALA ALA ARG ALA PHE ASP GLN ILE ASP ASN SEQRES 5 B 394 ALA PRO GLU GLU LYS ALA ARG GLY ILE THR ILE ASN THR SEQRES 6 B 394 SER HIS VAL GLU TYR ASP THR PRO THR ARG HIS TYR ALA SEQRES 7 B 394 HIS VAL ASP CYS PRO GLY HIS ALA ASP TYR VAL LYS ASN SEQRES 8 B 394 MET ILE THR GLY ALA ALA GLN MET ASP GLY ALA ILE LEU SEQRES 9 B 394 VAL VAL ALA ALA THR ASP GLY PRO MET PRO GLN THR ARG SEQRES 10 B 394 GLU HIS ILE LEU LEU GLY ARG GLN VAL GLY VAL PRO TYR SEQRES 11 B 394 ILE ILE VAL PHE LEU ASN LYS CYS ASP MET VAL ASP ASP SEQRES 12 B 394 GLU GLU LEU LEU GLU LEU VAL GLU MET GLU VAL ARG GLU SEQRES 13 B 394 LEU LEU SER GLN TYR ASP PHE PRO GLY ASP ASP THR PRO SEQRES 14 B 394 ILE VAL ARG GLY SER ALA LEU LYS ALA LEU GLU GLY ASP SEQRES 15 B 394 ALA GLU TRP GLU ALA LYS ILE LEU GLU LEU ALA GLY PHE SEQRES 16 B 394 LEU ASP SER TYR ILE PRO GLU PRO GLU ARG ALA ILE ASP SEQRES 17 B 394 LYS PRO PHE LEU LEU PRO ILE GLU ASP VAL PHE SER ILE SEQRES 18 B 394 SER GLY ARG GLY THR VAL VAL THR GLY ARG VAL GLU ARG SEQRES 19 B 394 GLY ILE ILE LYS VAL GLY GLU GLU VAL GLU ILE VAL GLY SEQRES 20 B 394 ILE LYS GLU THR GLN LYS SER THR CYS THR GLY VAL GLU SEQRES 21 B 394 MET PHE ARG LYS LEU LEU ASP GLU GLY ARG ALA GLY GLU SEQRES 22 B 394 ASN VAL GLY VAL LEU LEU ARG GLY ILE LYS ARG GLU GLU SEQRES 23 B 394 ILE GLU ARG GLY GLN VAL LEU ALA LYS PRO GLY THR ILE SEQRES 24 B 394 LYS PRO HIS THR LYS PHE GLU SER GLU VAL TYR ILE LEU SEQRES 25 B 394 SER LYS ASP GLU GLY GLY ARG HIS THR PRO PHE PHE LYS SEQRES 26 B 394 GLY TYR ARG PRO GLN PHE TYR PHE ARG THR THR ASP VAL SEQRES 27 B 394 THR GLY THR ILE GLU LEU PRO GLU GLY VAL GLU MET VAL SEQRES 28 B 394 MET PRO GLY ASP ASN ILE LYS MET VAL VAL THR LEU ILE SEQRES 29 B 394 HIS PRO ILE ALA MET ASP ASP GLY LEU ARG PHE ALA ILE SEQRES 30 B 394 ARG GLU GLY GLY ARG THR VAL GLY ALA GLY VAL VAL ALA SEQRES 31 B 394 LYS VAL LEU GLY SEQRES 1 C 12 SER BB9 MEN BB6 VAL BB7 GLY BB8 BB9 BB9 MH6 9BB SEQRES 1 D 12 SER BB9 MEN BB6 VAL BB7 GLY BB8 BB9 BB9 MH6 9BB MODRES 3U6K BB9 C 2 CYS MODRES 3U6K MEN C 3 ASN N-METHYL ASPARAGINE MODRES 3U6K BB6 C 4 CYS (2Z)-2-AMINO-3-SULFANYLBUT-2-ENOIC ACID MODRES 3U6K BB7 C 6 CYS MODRES 3U6K BB8 C 8 PHE (2S,3S)-BETA-HYDROXY-PHENYLALANINE MODRES 3U6K BB9 C 9 CYS MODRES 3U6K BB9 C 10 CYS MODRES 3U6K MH6 C 11 SER 3-HYDROXY-2-IMINOPROPANOIC ACID MODRES 3U6K BB9 D 2 CYS MODRES 3U6K MEN D 3 ASN N-METHYL ASPARAGINE MODRES 3U6K BB6 D 4 CYS (2Z)-2-AMINO-3-SULFANYLBUT-2-ENOIC ACID MODRES 3U6K BB7 D 6 CYS MODRES 3U6K BB8 D 8 PHE (2S,3S)-BETA-HYDROXY-PHENYLALANINE MODRES 3U6K BB9 D 9 CYS MODRES 3U6K BB9 D 10 CYS MODRES 3U6K MH6 D 11 SER 3-HYDROXY-2-IMINOPROPANOIC ACID HET BB9 C 2 6 HET MEN C 3 8 HET BB6 C 4 7 HET BB7 C 6 9 HET BB8 C 8 11 HET BB9 C 9 5 HET BB9 C 10 5 HET MH6 C 11 4 HET 9BB C 12 17 HET BB9 D 2 6 HET MEN D 3 8 HET BB6 D 4 7 HET BB7 D 6 9 HET BB8 D 8 11 HET BB9 D 9 5 HET BB9 D 10 5 HET MH6 D 11 4 HET 9BB D 12 17 HET GDP A 500 28 HET MG A 394 1 HET GDP B 500 28 HET MG B 394 1 HETNAM BB9 (2Z)-2-AMINO-3-SULFANYLPROP-2-ENOIC ACID HETNAM MEN N-METHYL ASPARAGINE HETNAM BB6 (2Z)-2-AMINO-3-SULFANYLBUT-2-ENOIC ACID HETNAM BB7 (2Z)-2-AMINO-4-METHOXY-3-SULFANYLBUT-2-ENOIC ACID HETNAM BB8 (2S,3S)-BETA-HYDROXY-PHENYLALANINE HETNAM MH6 3-HYDROXY-2-IMINOPROPANOIC ACID HETNAM 9BB TRANS-4-({[(E)-1-AMINO-2- HETNAM 2 9BB SULFANYLETHENYL]CARBAMOYL}OXY)CYCLOHEXANECARBOXYLIC HETNAM 3 9BB ACID HETNAM GDP GUANOSINE-5'-DIPHOSPHATE HETNAM MG MAGNESIUM ION HETSYN BB8 BETA-HYDROXY-PHENYLALANINE; THREO-BETA-HYDROXY-L- HETSYN 2 BB8 PHENYLALANINE; (BETAS)-BETA-HYDROXY-L-PHENYLALANINE; HETSYN 3 BB8 L-THREO-3-PHENYLSERINE; L-THREO-BETA-PHENYLSERINE; 3- HETSYN 4 BB8 HYDROXY-L-PHENYLALANINE FORMUL 3 BB9 6(C3 H5 N O2 S) FORMUL 3 MEN 2(C5 H10 N2 O3) FORMUL 3 BB6 2(C4 H7 N O2 S) FORMUL 3 BB7 2(C5 H9 N O3 S) FORMUL 3 BB8 2(C9 H11 N O3) FORMUL 3 MH6 2(C3 H5 N O3) FORMUL 3 9BB 2(C10 H16 N2 O4 S) FORMUL 5 GDP 2(C10 H15 N5 O11 P2) FORMUL 6 MG 2(MG 2+) FORMUL 9 HOH *145(H2 O) HELIX 1 1 GLY A 23 TYR A 39 1 17 HELIX 2 2 ALA A 45 ASN A 51 1 7 HELIX 3 3 GLY A 83 GLY A 94 1 12 HELIX 4 4 MET A 112 VAL A 125 1 14 HELIX 5 5 LYS A 136 VAL A 140 5 5 HELIX 6 6 GLU A 144 TYR A 160 1 17 HELIX 7 7 PRO A 163 THR A 167 5 5 HELIX 8 8 SER A 173 GLY A 180 1 8 HELIX 9 9 GLU A 183 ILE A 199 1 17 HELIX 10 10 ARG A 204 LYS A 208 5 5 HELIX 11 11 LYS A 282 ILE A 286 5 5 HELIX 12 12 SER A 312 GLY A 316 5 5 HELIX 13 13 GLY B 23 TYR B 39 1 17 HELIX 14 14 GLY B 83 GLY B 94 1 12 HELIX 15 15 MET B 112 GLY B 126 1 15 HELIX 16 16 ASP B 142 GLN B 159 1 18 HELIX 17 17 SER B 173 GLY B 180 1 8 HELIX 18 18 TRP B 184 ILE B 199 1 16 HELIX 19 19 LYS B 282 ILE B 286 5 5 HELIX 20 20 SER B 312 GLY B 316 5 5 SHEET 1 A 6 SER A 65 ASP A 70 0 SHEET 2 A 6 HIS A 75 ASP A 80 -1 O HIS A 78 N VAL A 67 SHEET 3 A 6 HIS A 11 ILE A 17 1 N VAL A 12 O ALA A 77 SHEET 4 A 6 GLY A 100 ALA A 106 1 O ILE A 102 N GLY A 15 SHEET 5 A 6 ILE A 130 ASN A 135 1 O ASN A 135 N VAL A 105 SHEET 6 A 6 ILE A 169 ARG A 171 1 O VAL A 170 N VAL A 132 SHEET 1 B 2 GLU A 54 ALA A 57 0 SHEET 2 B 2 ILE A 60 ASN A 63 -1 O ILE A 60 N ALA A 57 SHEET 1 C 7 LEU A 211 PRO A 213 0 SHEET 2 C 7 VAL A 291 ALA A 293 -1 O LEU A 292 N LEU A 212 SHEET 3 C 7 GLU A 241 VAL A 245 -1 N VAL A 245 O VAL A 291 SHEET 4 C 7 GLN A 251 MET A 260 -1 O SER A 253 N VAL A 242 SHEET 5 C 7 ASN A 273 LEU A 278 -1 O GLY A 275 N GLU A 259 SHEET 6 C 7 GLY A 224 ARG A 230 -1 N GLY A 229 O VAL A 274 SHEET 7 C 7 VAL A 217 ILE A 220 -1 N PHE A 218 O VAL A 226 SHEET 1 D 5 LEU A 211 PRO A 213 0 SHEET 2 D 5 VAL A 291 ALA A 293 -1 O LEU A 292 N LEU A 212 SHEET 3 D 5 GLU A 241 VAL A 245 -1 N VAL A 245 O VAL A 291 SHEET 4 D 5 GLN A 251 MET A 260 -1 O SER A 253 N VAL A 242 SHEET 5 D 5 LYS A 263 LEU A 265 -1 O LEU A 265 N VAL A 258 SHEET 1 E 2 ILE A 235 LYS A 237 0 SHEET 2 E 2 GLU A 267 ARG A 269 -1 O GLY A 268 N ILE A 236 SHEET 1 F 7 PRO A 300 ILE A 310 0 SHEET 2 F 7 ASN A 355 ALA A 367 -1 O LEU A 362 N THR A 302 SHEET 3 F 7 THR A 335 GLU A 342 -1 N GLU A 342 O VAL A 359 SHEET 4 F 7 GLN A 329 PHE A 332 -1 N PHE A 330 O VAL A 337 SHEET 5 F 7 ARG A 373 ARG A 377 -1 O ARG A 377 N GLN A 329 SHEET 6 F 7 THR A 382 GLY A 393 -1 O GLY A 386 N PHE A 374 SHEET 7 F 7 PRO A 300 ILE A 310 -1 N GLU A 305 O ALA A 389 SHEET 1 G 2 PHE A 322 PHE A 323 0 SHEET 2 G 2 MET A 349 VAL A 350 -1 O VAL A 350 N PHE A 322 SHEET 1 H 6 SER B 65 THR B 71 0 SHEET 2 H 6 ARG B 74 ASP B 80 -1 O HIS B 78 N VAL B 67 SHEET 3 H 6 HIS B 11 ILE B 17 1 N VAL B 12 O HIS B 75 SHEET 4 H 6 ALA B 101 ALA B 106 1 O VAL B 104 N ILE B 17 SHEET 5 H 6 ILE B 130 ASN B 135 1 O PHE B 133 N LEU B 103 SHEET 6 H 6 ILE B 169 ARG B 171 1 O VAL B 170 N LEU B 134 SHEET 1 I 2 GLU B 54 LYS B 56 0 SHEET 2 I 2 THR B 61 ASN B 63 -1 O ILE B 62 N GLU B 55 SHEET 1 J 7 LEU B 211 PRO B 213 0 SHEET 2 J 7 VAL B 291 ALA B 293 -1 O LEU B 292 N LEU B 212 SHEET 3 J 7 GLU B 241 VAL B 245 -1 N GLU B 243 O ALA B 293 SHEET 4 J 7 GLN B 251 MET B 260 -1 O SER B 253 N VAL B 242 SHEET 5 J 7 ASN B 273 ARG B 279 -1 O LEU B 277 N THR B 256 SHEET 6 J 7 GLY B 224 ARG B 230 -1 N GLY B 229 O VAL B 274 SHEET 7 J 7 VAL B 217 ILE B 220 -1 N ILE B 220 O GLY B 224 SHEET 1 K 5 LEU B 211 PRO B 213 0 SHEET 2 K 5 VAL B 291 ALA B 293 -1 O LEU B 292 N LEU B 212 SHEET 3 K 5 GLU B 241 VAL B 245 -1 N GLU B 243 O ALA B 293 SHEET 4 K 5 GLN B 251 MET B 260 -1 O SER B 253 N VAL B 242 SHEET 5 K 5 LYS B 263 LEU B 265 -1 O LYS B 263 N MET B 260 SHEET 1 L 2 ILE B 235 LYS B 237 0 SHEET 2 L 2 GLU B 267 ARG B 269 -1 O GLY B 268 N ILE B 236 SHEET 1 M 7 PRO B 300 ILE B 310 0 SHEET 2 M 7 ASN B 355 ALA B 367 -1 O LEU B 362 N THR B 302 SHEET 3 M 7 THR B 335 GLU B 342 -1 N THR B 340 O THR B 361 SHEET 4 M 7 GLN B 329 PHE B 332 -1 N PHE B 330 O VAL B 337 SHEET 5 M 7 ARG B 373 GLU B 378 -1 O ALA B 375 N TYR B 331 SHEET 6 M 7 ARG B 381 VAL B 391 -1 O VAL B 383 N ILE B 376 SHEET 7 M 7 PRO B 300 ILE B 310 -1 N TYR B 309 O ALA B 385 LINK C SER C 1 N BB9 C 2 1555 1555 1.36 LINK C SER C 1 SG BB9 C 2 1555 1555 1.73 LINK CA SER C 1 C BB9 C 10 1555 1555 1.42 LINK CB SER C 1 CB MH6 C 11 1555 1555 1.43 LINK C BB9 C 2 N MEN C 3 1555 1555 1.31 LINK C MEN C 3 SG BB6 C 4 1555 1555 1.75 LINK C MEN C 3 N BB6 C 4 1555 1555 1.34 LINK C BB6 C 4 N VAL C 5 1555 1555 1.32 LINK C VAL C 5 SG BB7 C 6 1555 1555 1.75 LINK C VAL C 5 N BB7 C 6 1555 1555 1.32 LINK C BB7 C 6 N GLY C 7 1555 1555 1.36 LINK C GLY C 7 N BB8 C 8 1555 1555 1.34 LINK C BB8 C 8 N BB9 C 9 1555 1555 1.31 LINK C BB8 C 8 SG BB9 C 9 1555 1555 1.78 LINK C BB9 C 9 N BB9 C 10 1555 1555 1.32 LINK C BB9 C 9 SG BB9 C 10 1555 1555 1.77 LINK C BB9 C 10 N MH6 C 11 1555 1555 1.34 LINK C MH6 C 11 N 9BB C 12 1555 1555 1.35 LINK C MH6 C 11 SG 9BB C 12 1555 1555 1.78 LINK C SER D 1 N BB9 D 2 1555 1555 1.35 LINK C SER D 1 SG BB9 D 2 1555 1555 1.75 LINK CA SER D 1 C BB9 D 10 1555 1555 1.41 LINK CB SER D 1 CB MH6 D 11 1555 1555 1.41 LINK C BB9 D 2 N MEN D 3 1555 1555 1.33 LINK C MEN D 3 SG BB6 D 4 1555 1555 1.76 LINK C MEN D 3 N BB6 D 4 1555 1555 1.34 LINK C BB6 D 4 N VAL D 5 1555 1555 1.32 LINK C VAL D 5 SG BB7 D 6 1555 1555 1.76 LINK C VAL D 5 N BB7 D 6 1555 1555 1.34 LINK C BB7 D 6 N GLY D 7 1555 1555 1.36 LINK C GLY D 7 N BB8 D 8 1555 1555 1.33 LINK C BB8 D 8 N BB9 D 9 1555 1555 1.33 LINK C BB8 D 8 SG BB9 D 9 1555 1555 1.79 LINK C BB9 D 9 N BB9 D 10 1555 1555 1.35 LINK C BB9 D 9 SG BB9 D 10 1555 1555 1.76 LINK C BB9 D 10 N MH6 D 11 1555 1555 1.33 LINK C MH6 D 11 N 9BB D 12 1555 1555 1.35 LINK C MH6 D 11 SG 9BB D 12 1555 1555 1.77 LINK OG1 THR A 25 MG MG A 394 1555 1555 2.25 LINK MG MG A 394 O HOH A 439 1555 1555 2.34 LINK MG MG A 394 O HOH A 441 1555 1555 2.70 LINK MG MG A 394 O HOH A 442 1555 1555 2.58 LINK MG MG A 394 O HOH A 444 1555 1555 2.19 LINK MG MG A 394 O3B GDP A 500 1555 1555 2.53 LINK OG1 THR B 25 MG MG B 394 1555 1555 2.43 LINK MG MG B 394 O HOH B 395 1555 1555 2.22 LINK MG MG B 394 O HOH B 396 1555 1555 2.31 LINK MG MG B 394 O HOH B 397 1555 1555 2.36 LINK MG MG B 394 O HOH B 403 1555 1555 2.27 LINK MG MG B 394 O3B GDP B 500 1555 1555 2.41 SITE 1 AC1 20 ASP A 21 HIS A 22 GLY A 23 LYS A 24 SITE 2 AC1 20 THR A 25 THR A 26 PHE A 46 ASN A 135 SITE 3 AC1 20 LYS A 136 ASP A 138 MET A 139 SER A 173 SITE 4 AC1 20 ALA A 174 LEU A 175 MG A 394 HOH A 439 SITE 5 AC1 20 HOH A 441 HOH A 444 ASP B 47 ASN B 51 SITE 1 AC2 7 THR A 25 CYS A 81 HOH A 439 HOH A 441 SITE 2 AC2 7 HOH A 442 HOH A 444 GDP A 500 SITE 1 AC3 17 HIS B 19 ASP B 21 HIS B 22 GLY B 23 SITE 2 AC3 17 LYS B 24 THR B 25 THR B 26 PHE B 46 SITE 3 AC3 17 ASN B 135 LYS B 136 ASP B 138 MET B 139 SITE 4 AC3 17 ALA B 174 MG B 394 HOH B 395 HOH B 396 SITE 5 AC3 17 HOH B 403 SITE 1 AC4 6 THR B 25 HOH B 395 HOH B 396 HOH B 397 SITE 2 AC4 6 HOH B 403 GDP B 500 SITE 1 AC5 24 GLU A 215 ASP A 216 PHE A 218 ILE A 220 SITE 2 AC5 24 THR A 228 THR A 256 GLY A 257 GLU A 259 SITE 3 AC5 24 PHE A 261 ARG A 262 ASN A 273 VAL A 274 SITE 4 AC5 24 GLY A 275 LEU A 277 ARG A 381 HOH A 402 SITE 5 AC5 24 THR B 38 TYR B 39 ARG B 318 THR B 320 SITE 6 AC5 24 PRO B 321 PHE B 323 HOH B 423 HOH C 18 SITE 1 AC6 22 TYR A 39 PRO A 72 THR A 320 PRO A 321 SITE 2 AC6 22 PHE A 323 TYR A 326 HOH A 448 GLU B 215 SITE 3 AC6 22 ASP B 216 ARG B 223 THR B 228 GLY B 257 SITE 4 AC6 22 VAL B 258 GLU B 259 PHE B 261 ASN B 273 SITE 5 AC6 22 VAL B 274 GLY B 275 LEU B 277 HOH B 447 SITE 6 AC6 22 HOH D 13 HOH D 143 CRYST1 80.372 82.216 129.900 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012442 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012163 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007698 0.00000